• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对艾滋病毒的暴露前预防(PrEP):疗效、安全性及不确定性

Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties.

作者信息

Sanchez Conde Matilde, Vivancos Gallego María Jesús, Moreno Guillen Santiago

机构信息

Infectious Disease Unit, Hospital Ramón y Cajal, Madrid. Instituto Ramón y Cajal de Investigación Sanitaria (Ramón y Cajal Health Research Institute) (IRYCIS), Madrid..

Infectious Disease Unit, Hospital Ramón y Cajal, Madrid. Instituto Ramón y Cajal de Investigación Sanitaria (Ramón y Cajal Health Research Institute) (IRYCIS), Madrid. Department of Medicine, University of Alcalá de Henares, Madrid..

出版信息

Farm Hosp. 2017 Sep 1;41(5):630-637. doi: 10.7399/fh.10821.

DOI:10.7399/fh.10821
PMID:28847253
Abstract

Despite the global stabilization of the number of new HIV infections in recent years, there has been an increase in new infections among men who have sex with men. This fact indicates the lack of effectiveness of the measures and prevention campaigns established so far for this group.  It is therefore necessary to implement alternative preventive measures for them. Pre-exposure pharmacological prophylaxis (PrEP) is one of the best evaluated options and has had high protection rates in both clinical and real-life trials. The strategy has also shown an adequate profile in terms of safety, tolerance, adverse effects and cost-effectiveness in the studies carried out to assess this important topic.

摘要

尽管近年来全球新增艾滋病毒感染人数趋于稳定,但男男性行为者中的新感染病例却有所增加。这一事实表明,迄今为止为该群体制定的措施和预防活动缺乏成效。因此,有必要为他们实施替代性预防措施。暴露前药物预防(PrEP)是评估效果最佳的选择之一,在临床试验和实际生活试验中均具有很高的保护率。在评估这一重要课题的研究中,该策略在安全性、耐受性、不良反应和成本效益方面也显示出良好表现。

相似文献

1
Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties.针对艾滋病毒的暴露前预防(PrEP):疗效、安全性及不确定性
Farm Hosp. 2017 Sep 1;41(5):630-637. doi: 10.7399/fh.10821.
2
A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.洛杉矶县男男性行为者中 HIV 预防的暴露前预防的成本效益分析。
Clin Infect Dis. 2016 Dec 1;63(11):1495-1504. doi: 10.1093/cid/ciw578. Epub 2016 Aug 23.
3
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.用于预防艾滋病病毒的暴露前预防:安全性问题。
Drug Saf. 2017 Apr;40(4):273-283. doi: 10.1007/s40264-017-0505-6.
4
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.按需暴露前预防治疗用于男男性行为人群的有效性、安全性和对性行为影响的观察性队列研究。
Lancet HIV. 2017 Sep;4(9):e402-e410. doi: 10.1016/S2352-3018(17)30089-9. Epub 2017 Jul 23.
5
Pre-exposure prophylaxis: a useful tool to prevent human immunodeficiency virus infection?暴露前预防:预防人类免疫缺陷病毒感染的有效工具?
Clin Microbiol Infect. 2016 Sep;22(9):757-767. doi: 10.1016/j.cmi.2016.08.029. Epub 2016 Sep 8.
6
A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China.中国男男性行为人群艾滋病预防的医学干预数学模型
BMC Infect Dis. 2018 Nov 28;18(1):600. doi: 10.1186/s12879-018-3516-8.
7
HIV preexposure prophylaxis: An essential, safe and effective prevention tool for sexual health.HIV 暴露前预防:性健康的重要、安全且有效的预防工具。
Med Mal Infect. 2018 Aug;48(5):318-326. doi: 10.1016/j.medmal.2018.01.009. Epub 2018 Feb 9.
8
The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco.在旧金山男男性行为者中存在耐药性的情况下,口服 HIV 暴露前预防和早期抗逆转录病毒治疗的成本效益。
BMC Med. 2018 Apr 24;16(1):58. doi: 10.1186/s12916-018-1047-1.
9
Untangling the cost-effectiveness knot: who is oral antiretroviral HIV pre-exposure prophylaxis really for?解开成本效益的难题:口服抗逆转录病毒药物暴露前预防究竟适用于谁?
Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):167-70. doi: 10.1586/14737167.2014.887447. Epub 2014 Feb 19.
10
Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?我们应该担心替诺福韦/恩曲他滨暴露前预防产生的耐药性吗?
Curr Opin HIV AIDS. 2016 Jan;11(1):49-55. doi: 10.1097/COH.0000000000000209.

引用本文的文献

1
Understanding the cost-utility of implementing HIV self-testing with digital-based supports.了解实施基于数字支持的艾滋病毒自我检测的成本效益。
Front Public Health. 2025 Jan 14;12:1440104. doi: 10.3389/fpubh.2024.1440104. eCollection 2024.
2
The challenges of Chile to achieve control the HIV/AIDS pandemic the year 2030: A review.智利在 2030 年实现控制艾滋病毒/艾滋病大流行的挑战:综述。
Medicine (Baltimore). 2024 Jul 26;103(30):e38288. doi: 10.1097/MD.0000000000038288.
3
From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications.
从创新到实施:HIV暴露前预防的演变及未来影响
Pathogens. 2023 Jul 9;12(7):924. doi: 10.3390/pathogens12070924.
4
Nurse Practitioner-Led Integrated Rapid Access to HIV Prevention for People Who Inject Drugs (iRaPID): Protocol for a Pilot Randomized Controlled Trial.由执业护士主导的针对注射吸毒者的艾滋病预防综合快速通道项目(iRaPID):一项试点随机对照试验方案
JMIR Res Protoc. 2022 Oct 11;11(10):e42585. doi: 10.2196/42585.
5
Understanding the Association between PrEP Stigma and PrEP Cascade Moderated by the Intensity of HIV Testing.了解由HIV检测强度调节的暴露前预防污名与暴露前预防级联之间的关联。
Trop Med Infect Dis. 2022 May 16;7(5):74. doi: 10.3390/tropicalmed7050074.